Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 33 | 33 |
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 17 | 17 |
| 1998 | 0 | 28 | 28 |
| 1999 | 0 | 30 | 30 |
| 2000 | 0 | 23 | 23 |
| 2001 | 1 | 33 | 34 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 34 | 34 |
| 2004 | 1 | 40 | 41 |
| 2005 | 1 | 30 | 31 |
| 2006 | 1 | 21 | 22 |
| 2007 | 1 | 42 | 43 |
| 2008 | 1 | 48 | 49 |
| 2009 | 1 | 44 | 45 |
| 2010 | 0 | 46 | 46 |
| 2011 | 0 | 38 | 38 |
| 2012 | 0 | 33 | 33 |
| 2013 | 0 | 35 | 35 |
| 2014 | 0 | 31 | 31 |
| 2015 | 1 | 24 | 25 |
| 2016 | 0 | 39 | 39 |
| 2017 | 0 | 38 | 38 |
| 2018 | 1 | 33 | 34 |
| 2019 | 1 | 38 | 39 |
| 2020 | 0 | 32 | 32 |
| 2021 | 0 | 22 | 22 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 13 | 13 |
| 2024 | 0 | 20 | 20 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 01; 23(1).
-
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference. Oncoimmunology. 2025 Dec; 14(1):2432726.
-
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol. 2024 Dec; 42(34):4095-4102.
-
Invasive Treatment Strategy for Older Patients with Myocardial Infarction. N Engl J Med. 2024 Nov 07; 391(18):1673-1684.
-
A Glutathione-Consuming Bimetallic Nano-Bomb with the Combination of Photothermal and Chemodynamic Therapy for Tumors: An in vivo and in vitro Study. Int J Nanomedicine. 2024; 19:8541-8553.
-
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer. Clin Lung Cancer. 2024 Dec; 25(8):e448-e452.
-
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials. Eur J Cancer. 2024 Sep; 209:114264.
-
Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol. 2024 Aug; 25(8):e352-e362.
-
Assessment of Thrombectomy versus Combined Thrombolysis and Thrombectomy in Patients with Acute Ischemic Stroke and Medium Vessel Occlusion. Radiology. 2024 08; 312(2):e233041.
-
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 08; 22(6):366-375.